(FY)Dec 31, 2023 | (Q6)Jun 30, 2023 | (FY)Dec 31, 2022 | (Q6)Jun 30, 2022 | (FY)Dec 31, 2021 | (Q6)Jun 30, 2021 | (FY)Dec 31, 2020 | (Q6)Jun 30, 2020 | (FY)Dec 31, 2019 | (Q6)Jun 30, 2019 | |
---|---|---|---|---|---|---|---|---|---|---|
Cash flow from operating activities | ||||||||||
Earning before tax | 33.65%-152.22M | ---- | 64.52%-229.41M | ---- | -81.68%-646.61M | ---- | -1,061.60%-355.91M | ---- | -51.78%-30.64M | ---- |
Profit adjustment | ||||||||||
Interest (income) - adjustment | 66.67%-2K | ---- | -20.00%-6K | ---- | 98.37%-5K | ---- | 79.10%-307K | ---- | 28.93%-1.47M | ---- |
Attributable subsidiary (profit) loss | ---- | ---- | -99.55%766K | ---- | 17.29%169.56M | ---- | 1,306.86%144.57M | ---- | -47.37%10.28M | ---- |
Impairment and provisions: | -75.68%43.2M | ---- | -42.01%177.61M | ---- | 138.07%306.3M | ---- | --128.66M | ---- | ---- | ---- |
-Impairment of property, plant and equipment (reversal) | ---- | ---- | ---- | ---- | 29.64%114M | ---- | --87.94M | ---- | ---- | ---- |
-Other impairments and provisions | -75.68%43.2M | ---- | -7.64%177.61M | ---- | 372.21%192.3M | ---- | --40.72M | ---- | ---- | ---- |
Revaluation surplus: | -83.97%544K | ---- | -86.40%3.39M | ---- | -67.98%24.94M | ---- | 3,337.42%77.89M | ---- | --2.27M | ---- |
-Fair value of investment properties (increase) | -83.97%544K | ---- | -86.40%3.39M | ---- | -67.98%24.94M | ---- | 3,337.42%77.89M | ---- | --2.27M | ---- |
Asset sale loss (gain): | --10.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
-Loss (gain) from sale of subsidiary company | --10.63M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Depreciation and amortization: | -64.49%125K | ---- | 6.34%352K | ---- | -18.47%331K | ---- | 174.32%406K | ---- | 46.53%148K | ---- |
-Depreciation | -64.49%125K | ---- | 6.34%352K | ---- | -18.47%331K | ---- | 174.32%406K | ---- | --148K | ---- |
Financial expense | 19.82%91.59M | ---- | -52.37%76.44M | ---- | 1,211.60%160.5M | ---- | -47.74%12.24M | ---- | -6.34%23.41M | ---- |
Special items | --105K | ---- | ---- | ---- | --11.28M | ---- | ---- | ---- | ---- | ---- |
Operating profit before the change of operating capital | -120.72%-6.04M | ---- | 10.83%29.15M | ---- | 248.64%26.3M | ---- | 88.81%7.54M | ---- | -81.98%4M | ---- |
Change of operating capital | ||||||||||
Inventory (increase) decrease | ---1.31M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Accounts receivable (increase)decrease | 55.83%-10.16M | ---- | 47.85%-23M | ---- | -387.23%-44.1M | ---- | 104.66%15.35M | ---- | -1,125.54%-329.62M | ---- |
Accounts payable increase (decrease) | 2,054.48%11.31M | ---- | -83.98%525K | ---- | -32.99%3.28M | ---- | -77.45%4.89M | ---- | 352.88%21.7M | ---- |
Cash from business operations | -192.90%-6.2M | ---- | 145.95%6.67M | ---- | -152.26%-14.52M | ---- | 109.14%27.79M | ---- | -2,184.69%-303.93M | ---- |
Other taxs | ---41K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Special items of business | ---- | -104.10%-185K | ---- | 128.48%4.51M | ---- | -109.41%-15.85M | ---- | 1,077.50%168.41M | ---- | -140.97%-17.23M |
Net cash from operations | -193.51%-6.24M | -104.10%-185K | 145.95%6.67M | 128.48%4.51M | -152.26%-14.52M | -109.41%-15.85M | 109.14%27.79M | 1,077.50%168.41M | -2,184.69%-303.93M | -140.97%-17.23M |
Cash flow from investment activities | ||||||||||
Interest received - investment | -66.67%2K | ---- | 20.00%6K | ---- | -98.37%5K | ---- | -79.10%307K | ---- | -28.93%1.47M | ---- |
Sale of subsidiaries | --989K | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Other items in the investment business | ---- | -66.67%1K | ---- | 0.00%3K | ---- | -96.94%3K | ---- | -88.24%98K | ---- | -24.89%833K |
Adjustment items of investment business | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---135.32M | ---- |
Net cash from investment operations | 16,416.67%991K | -66.67%1K | 20.00%6K | 0.00%3K | -98.37%5K | -96.94%3K | 100.23%307K | -88.24%98K | -6,004.10%-133.85M | -24.89%833K |
Net cash before financing | -178.59%-5.25M | -104.07%-184K | 146.01%6.68M | 128.51%4.52M | -151.67%-14.52M | -109.40%-15.84M | 106.42%28.1M | 1,127.76%168.51M | -3,866.82%-437.78M | -137.99%-16.4M |
Cash flow from financing activities | ||||||||||
New borrowing | --5.12M | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Refund | 92.18%-101K | ---- | 68.60%-1.29M | ---- | 70.33%-4.12M | ---- | 87.28%-13.87M | ---- | -581.25%-109M | ---- |
Interest paid - financing | ---- | ---- | ---- | ---- | ---- | ---- | ---2.08M | ---- | ---- | ---- |
Other items of the financing business | ---- | 85.48%-162K | ---- | -506.52%-1.12M | ---- | 0.00%-184K | ---- | 98.43%-184K | 226.90%1.67M | 6.40%-11.7M |
Net cash from financing operations | 390.83%4.88M | 85.48%-162K | 62.56%-1.68M | -506.52%-1.12M | 72.53%-4.48M | 0.00%-184K | 84.80%-16.32M | 98.43%-184K | -153.78%-107.39M | 6.40%-11.7M |
Effect of rate | 135.08%1.58M | 32.88%-1.13M | -290.35%-4.52M | -425.24%-1.69M | -49.47%2.37M | 104.94%519K | 179.28%4.69M | -488.79%-10.5M | 80.56%-5.92M | 67.86%-1.78M |
Net Cash | -107.32%-366K | -110.17%-346K | 126.31%5M | 121.22%3.4M | -261.39%-19M | -109.52%-16.03M | 102.16%11.77M | 699.12%168.33M | -921.83%-545.17M | -191.63%-28.1M |
Begining period cash | 26.05%2.35M | 26.05%2.35M | -89.93%1.86M | -89.93%1.86M | 813.59%18.49M | 813.59%18.49M | -99.63%2.02M | -99.63%2.02M | -13.16%553.11M | -13.16%553.11M |
Cash at the end | 51.90%3.57M | -75.72%868K | 26.05%2.35M | 19.89%3.58M | -89.93%1.86M | -98.13%2.98M | 813.59%18.49M | -69.45%159.85M | -99.63%2.02M | -20.97%523.23M |
Cash balance analysis | ||||||||||
Currency Unit | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD | HKD |
Accounting Standards | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS | HKAS |
Auditor | -- | -- | -- | -- | -- | -- | Guowei Certified Public Accountants Limited | -- | -- | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.
No Data
No Data